BUS 302 Management Concepts
Instructor: Written By
March 1, 2015
PROFILE OF MR.ARTHUR D. LEVINSON Mr Levinson is current CEO of Calico (Google Venture) since September 2013 and chairman of Apple Inc since 2011 to the present. In addition to serving on the board Apple Inc. since 2000 Levinson is currently on the board of directors of the Broad Institute. He has served previously on the board of directors at F. Hoffmann-La Roche (2010-2014), NGM Biopharmaceuticals (2009-2014) and Amyris Biotechnologies (2009-20014). He was the CEO of Greentech from 1995 to 2009 and Director of Google from 2004 to 2009. He has also authored and coauthored over 80 Scientific …show more content…
He was able to restore the company’s reputation from these allegations and initial failures.
In March of 2003 the drug Avastin failed final stages of testing for treatment of breast cancer and lead to a huge loss on the stock market and investors demanding answers. He was able to take the data from the final testing and his company was able to find that the drug Avastin significantly extended the life of patients with colon cancer.(Levine, 2004) It was filed for approval in September 2003 and now has become Genentech’s top drug and is considered a billion dollar a year drug. Greentech went on to get Raptivia and Psoriasis unanimously One change he had made was that he went and started ranking the drugs they were working on scientific feasibility, medical need, market potential, market protection and manufacturing economy. (Bloomberg,2004)
Levinson was able to balance his roles as a CEO and as a Scientist as he had a specific background that drove his inspiration and better equipped him to make not only better decisions but enabled him to motivate his employees. He has made Genentech a powerhouse in the biotech industry worth a reported $92 billion with several long term medications that help people live longer and better lives with uncureable diseases. He has expanded Greentech into other markets with treatments for drugs that treat a variety of